X
  • With a new dataset describing hundreds of samples from AML patients, researchers can learn what drugs may work best for specific subsets of patients. This image relates sensitivity to the cancer drug ibrutinib to co-occurrences of two types of genetic changes found in tumor samples.
    J. Tyner et al./ Nature 2018
    With a new dataset describing hundreds of samples from AML patients, researchers can learn what drugs may work best for specific subsets of patients. This image relates sensitivity to the cancer drug ibrutinib to co-occurrences of two types of genetic changes found in tumor samples.
Chat now!